Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy (Gemtrans)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
University of Oxford
Information provided by (Responsible Party):
Rebecca Robinson, Christie Hospital NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01343121
First received: April 7, 2011
Last updated: February 3, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)